An Indian court has allowed Dr. Reddy’s Laboratories Ltd. to manufacture and export generic versions of Novo Nordisk A/S’s obesity and diabetes drugs, ahead of global patent expiries in 2026. Novo ...

Oct 30 (Reuters) - Shares of Indian generic drugmaker Dr Reddy's Laboratories (REDY.NS), opens new tab declined more than 5% on Thursday, after the firm received a non-compliance notice for its ...

Dr. Reddy’s Laboratories remains a compelling buy due to underappreciated growth in biosimilars and GLP-1 segments, despite near-term headwinds. RDY's Q2 FY26 results showed modest revenue growth, ...

Oct 24 (Reuters) - Indian generic drugmaker Dr Reddy's Laboratories (REDY.NS), opens new tab reported second-quarter profit below estimates on Friday, hurt by higher costs and stiff competition for ...

Andhra Pradesh Chief Minister N. Chandrababu Naidu has set an ambitious goal to make the state single-use plastic-free by June 2026, as part of a comprehensive green initiative launched by the state ...

A pre-approval inspection by the FDA of Dr. Reddy’s Bachupally biologics production facility earlier this month resulted in the drugmaker being issued a Form 483. The FDA reprimand, which was ...

Cowboys cornerback DaRon Bland played all 63 of the defensive unit's snaps in the Week 1 loss to Philadelphia. He'll add exactly zero in Week 2's home opener, and it's unclear when he'll be back on ...

Vignesh Nathan successfully defended his Ph.D. dissertation on July 11, 2025. Vignesh is originally from Indianapolis, Indiana, and he received his B.S. from Purdue University. Vignesh's dissertation ...

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.

Dr. Vignesh Kasinath, an assistant professor of biochemistry at University of Colorado Boulder, has joined the Pew Scholars Program in the Biomedical Sciences with 21 other early-career scientists.